We are live on ! Find out more
COLL icon

Collegium Pharmaceutical
COLL

158 hedge funds and large institutions have $898M invested in Collegium Pharmaceutical in 2021 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 61 increasing their positions, 43 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

42% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 43

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% less capital invested

Capital invested by funds: $900M → $898M (-$2.6M)

1.58% less ownership

Funds ownership: 109.35% → 107.77% (-1.6%)

3% less funds holding

Funds holding: 163 → 158 (-5)

15% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 20

88% less call options, than puts

Call options by funds: $2K | Put options by funds: $16K

Holders
158
Holders Change
-5
Holders Change %
-3.07%
% of All Funds
2.75%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
17
Increased
61
Reduced
43
Closed
20
Calls
$2K
Puts
$16K
Net Calls
-$14K
Net Calls Change
-$1M

Top Buyers

1
Principal Financial Group
Principal Financial Group
Iowa
+$7.48M
2
EAM
Eventide Asset Management
Massachusetts
+$4.66M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$4.47M
4
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
+$4.37M
5
Federated Hermes
Federated Hermes
Pennsylvania
+$3.96M

Top Sellers

1
APM
Avidity Partners Management
Texas
-$17.5M
2
SAM
Silvercrest Asset Management
New York
-$5.3M
3
BlackRock
BlackRock
New York
-$5.08M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$3.16M
5
RHJA
Rice Hall James & Associates
California
-$2.92M
Name Holding Trade Value Shares
Change 		Change in
Stake
Thrivent Financial for Lutherans
76
Thrivent Financial for Lutherans
Minnesota
$681K +$6.1K +264 +0.9%
UBS AM
77
UBS AM
Illinois
$679K +$6.72K +291 +1%
SGI
78
Summit Global Investments
Utah
$678K +$663K +28,700 New
Comerica Bank
79
Comerica Bank
Texas
$657K -$54.4K -2,354 -7%
JP Morgan Chase
80
JP Morgan Chase
New York
$655K -$627K -27,143 -50%
CS
81
Credit Suisse
Switzerland
$644K +$3.97K +172 +0.6%
COPPSERS
82
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$639K +$5.68K +246 +0.9%
TPSF
83
Texas Permanent School Fund
Texas
$621K +$6.98K +302 +1%
Citigroup
84
Citigroup
New York
$594K +$79.1K +3,425 +16%
State of Tennessee, Department of Treasury
85
State of Tennessee, Department of Treasury
Tennessee
$594K +$294K +12,745 +103%
SOADOR
86
State of Alaska Department of Revenue
Alaska
$576K +$19.8K +858 +4%
T. Rowe Price Associates
87
T. Rowe Price Associates
Maryland
$538K -$70.6K -3,058 -12%
Los Angeles Capital Management
88
Los Angeles Capital Management
California
$517K -$27.7K -1,200 -5%
HF
89
HRT Financial
New York
$514K +$503K +21,774 New
CGH
90
Crossmark Global Holdings
Texas
$501K +$2.54K +110 +0.5%
SGAM
91
Smith Group Asset Management
Texas
$500K -$4.74K -205 -1%
Citadel Advisors
92
Citadel Advisors
Florida
$489K -$686K -29,685 -59%
Manulife (Manufacturers Life Insurance)
93
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$482K +$11.4K +495 +2%
AB
94
Amalgamated Bank
New York
$448K +$437K +18,933 New
Qube Research & Technologies (QRT)
95
Qube Research & Technologies (QRT)
United Kingdom
$426K -$42.6K -1,844 -9%
PC
96
Prairiewood Capital
North Dakota
$407K +$398K +17,208 New
IA
97
IndexIQ Advisors
New York
$404K +$5.43K +235 +1%
ProShare Advisors
98
ProShare Advisors
Maryland
$388K +$32.7K +1,414 +9%
IFWM
99
Institute for Wealth Management
Colorado
$383K – – –
UBS Group
100
UBS Group
Switzerland
$376K -$79K -3,421 -18%
2 3
4
5 6

COLL Hedge Fund Activity: Q2 2021 in Review

158 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q2 2021, worth a combined $898M — down 0.29% from $900M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of COLL and 17 opened new positions — a net loss of 3 holders — while 43 trimmed existing stakes and 61 added.

The largest buyer was Principal Financial Group, adding an estimated $7.48M. The largest seller was Avidity Partners Management, exiting entirely with an estimated $17.5M sold.

  • 158 institutional investors held Collegium Pharmaceutical (COLL) as of Q2 2021, down from 163 in Q1 2021.
  • Funds reported $898M of Collegium Pharmaceutical stock for Q2 2021, down 0.29% quarter-over-quarter.
  • 17 funds opened new Collegium Pharmaceutical positions in Q2 2021 and 20 closed out, a net change of -3 holders.
  • The largest Collegium Pharmaceutical buyer in Q2 2021 was Principal Financial Group, an estimated $7.48M added.
  • The largest Collegium Pharmaceutical seller in Q2 2021 was Avidity Partners Management, an estimated $17.5M sold.

Based on aggregated 13F filings for Q2 2021.